The trading halt is requested until commencement of trading on Monday 8th January 2018 or upon the release to the market of an announcement regarding a significant and strategic medical product joint venture deal being finalised by its subsidiary Medical Cannabis Limited with a Canadian cannabis company.
The Company is not aware of any reason why the trading halt should not be granted.
Sholom D Feldman Executive Director / Company Secretary
QBL Price at posting:
5.2¢ Sentiment: Hold Disclosure: Held